Royce & Associates LP Ironwood Pharmaceuticals Inc Transaction History

Royce & Associates LP

$9.35 Billion
Q3 2025

A detailed history of Royce & Associates LP transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Royce & Associates LP holds 300,619 shares of IRWD stock, worth $943,943. This represents 0.0% of its overall portfolio holdings.

Number of Shares

300,619

Previous 506,060 40.6%

Holding current value

$943,943

Previous $364,000 7.97%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 12, 2025	SELL	$0.69 - $1.46 $141,754 - $299,943	-205,441 Reduced 40.6%	300,619 $393,000
Q2 2025 Aug 11, 2025	SELL	$0.57 - $1.44 $130,744 - $330,301	-229,376 Reduced 31.19%	506,060 $364,000
Q4 2024 Feb 10, 2025	BUY	$3.34 - $5.04 $242,156 - $365,410	72,502 Added 10.94%	735,436 $3.26 Million
Q3 2024 Nov 06, 2024	BUY	$3.93 - $7.04 $252,907 - $453,045	64,353 Added 10.75%	662,934 $2.72 Million
Q2 2024 Aug 13, 2024	BUY	$5.58 - $8.61 $42,279 - $65,237	7,577 Added 1.28%	598,581 $3.9 Million

Q1 2024 May 13, 2024	BUY	$8.32 - $15.45 $2.43 Million - $4.52 Million	292,241 Added 97.82%	591,004 $5.15 Million
Q4 2023 Feb 12, 2024	BUY	$8.79 - $11.51 $123,174 - $161,289	14,013 Added 4.92%	298,763 $3.42 Million
Q3 2023 Nov 09, 2023	BUY	$8.25 - $11.35 $17,572 - $24,175	2,130 Added 0.75%	284,750 $2.74 Million
Q2 2023 Aug 07, 2023	SELL	$10.1 - $11.6 $16.2 Million - $18.6 Million	-1,603,627 Reduced 85.02%	282,620 $3.01 Million
Q1 2023 May 04, 2023	BUY	$10.37 - $12.56 $2.19 Million - $2.65 Million	210,758 Added 12.58%	1,886,247 $19.8 Million
Q4 2022 May 23, 2023	SELL	$9.9 - $12.43 $2.09 Million - $2.62 Million	-210,758 Reduced 11.17%	1,675,489 $20.8 Million
Q4 2022 Feb 13, 2023	SELL	$9.9 - $12.43 $26,947 - $33,834	-2,722 Reduced 0.16%	1,675,489 $20.8 Million
Q3 2022 Nov 03, 2022	BUY	$10.14 - $12.38 $1.87 Million - $2.29 Million	184,574 Added 12.36%	1,678,211 $17.4 Million
Q2 2022 Aug 04, 2022	BUY	$11.05 - $12.72 $3.68 Million - $4.23 Million	332,791 Added 28.67%	1,493,637 $17.2 Million
Q1 2022 May 05, 2022	BUY	$10.61 - $12.88 $7.21 Million - $8.76 Million	679,997 Added 141.42%	1,160,846 $14.6 Million
Q4 2021 Feb 07, 2022	BUY	$10.86 - $13.95 $5.22 Million - $6.71 Million	480,849 New	480,849 $5.61 Million
Q3 2020 Nov 12, 2020	SELL	$8.99 - $10.74 $20,928 - $25,002	-2,328 Closed	0 $0
Q2 2020 Aug 07, 2020	BUY	$9.14 - $11.97 $4,231 - $5,542	463 Added 24.83%	2,328 $24,000
Q1 2020 May 12, 2020	BUY	$8.58 - $14.01 $16,001 - $26,128	1,865 New	1,865 $19,000

Others Institutions Holding IRWD

# of Institutions

186

Shares Held

160M

Call Options Held

11.2M

Put Options Held

11.7K

View Full List

About IRONWOOD PHARMACEUTICALS INC

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $481M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

More about IRWD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royce & Associates LP, based on Form 13F filings with the SEC.

News

Stay updated on Royce & Associates LP with notifications on news.

Account

Royce & Associates LP Ironwood Pharmaceuticals Inc Transaction History